SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using an alpha–particle emitting radioisotope, actinium–225, for potential cancer treatments The two sides aim to submit an Investigational New Drug application […]
#Rosal Top Picks
Recent Posts
- Sunmed™ | Your CBD Store® Calls for Transparency as
- Passes vehemently denies any allegations suggesting
- NEW YORK, March 14, 2025 /PRNewswire/ — In an
- Bioretec Ltd Company announcement 14 March 2025 at
- The board brings together decades of leadership
